Xizang Weixinkang Pharmaceutical Co., Ltd. Class ASSE: 603676

Announcement on Subsidiary Obtaining Drug Registration Certificate for Compound Amino Acid Injection (18AA-VII)

· Issued by Xizang Weixinkang Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Subsidiary Obtaining Drug Registration Certificate for Compound Amino Acid Injection (18AA-VII)

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment